Ralf Kuriyel
Net worth: 1 M $ as of 30/06/2026
Net worth: 1 M $ as of 30/06/2026
Presently, Ralf Kuriyel is Senior Vice President-Research & Development at Repligen Corp. In the past he was Vice President-Research & Development for Pall Life Sciences and Vice President-Field Applications R&D at Pall Corp. Mr. Kuriyel received an undergraduate degree and a graduate degree from Rensselaer Polytechnic Institute.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIGEN CORPORATION 0.02% | 16/03/2026 | 9,421 ( 0.02% ) | 1 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2016 |
| Companies | Position | End |
|---|---|---|
| PALL CORPORATION | Corporate Officer/Principal | 01/10/2016 |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Pall Corp.
Pall Corp. Industrial MachineryProducer Manufacturing Designs, manufactures and markets filtration & separation equipment | Producer Manufacturing |
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Develops and manufactures of biotherapeutics, cell and gene therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions